This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2011 Remove Pharmaceutical manufacturing Remove Prescription
article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

NOVEMBER 14, 2023

It leverages GoodRx’s reach and scale to broaden access and affordability for people living with diabetes and means that all Americans with a valid prescription, regardless of insurance status, can use GoodRx at over 70,000 U.S. The price is available to cash-paying patients with a valid prescription. References: 1.

Retail 52
Retail Pharmaceutical manufacturing Sales Insurance 52
article thumbnail

Everything You Need to Know About Market Access in China

PM360

DECEMBER 20, 2023

Medicines that are not listed in either Category 1 or 2, such as over the counter (OTC) and other prescription therapies (pembrolizumab, CAR-T therapy, etc.), Conclusion In conclusion, the dynamic landscape of the Chinese healthcare system presents compelling reasons for pharmaceutical manufacturers to consider venturing into the market.

Marketing 105
Marketing Insurance Medical Manufacturing 105
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024